Home/Filings/4/0001104659-22-072369
4//SEC Filing

Fitzgerald Thomas A 4

Accession 0001104659-22-072369

CIK 0001829635other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:01 PM ET

Size

4.5 KB

Accession

0001104659-22-072369

Insider Transaction Report

Form 4
Period: 2022-06-16
Fitzgerald Thomas A
DirectorVP, Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-06-16$1.27/sh+12,000$15,240139,377 total

Issuer

Transcode Therapeutics, Inc.

CIK 0001829635

Entity typeother

Related Parties

1
  • filerCIK 0001854168

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:01 PM ET
Size
4.5 KB